Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 2,257-2,268 of 5,650
Drug study icon
RecruitingNCT04781140

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

This study is looking at evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD for people with Attention-Deficit/Hyperactivity Disorder. Participants receive 100mg SPN-812 or placebo and complete study visits and assessments.

Multiple locations, including Saraland
ADHDDrugA study involving a medication or substance.From 48 Months to 69 Months
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
RecruitingNCT06931080

EB-1020 for ADHD

This study is recruiting in Japan. It is testing EB-1020 for ADHD.

In Tokyo
ADHDDrugFrom 18 Years to 55 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.